EMNUVAQ
Live / Applied — Response to non-final action entered (as of 08 Oct 2026)
What this means for you
Not registered yet, but its 01 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99737665
- Mark type
- Word mark
- Filed
- 01 Apr 2026
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in immunology; Antibodies for medical purposes; Pharmaceutical preparations for the treatment and prevention of respiratory and inflammatory diseases and disorders; Vaccines for human use
Owner
- Sanofi R&D Vaccins, Lyon, FR
Prosecution history
- 08 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Oct 2026 — ASSIGNED TO LIE
- 05 Oct 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 27 Jun 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 27 Jun 2026 — LETTER OF SUSPENSION E-MAILED
- 27 Jun 2026 — SUSPENSION LETTER WRITTEN
- 26 Jun 2026 — ASSIGNED TO EXAMINER
- 01 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 01 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Apr 2026 — NEW APPLICATION ENTERED